Regression of pulmonary arteriovenous malformations following heart transplantation

Jacqueline M. Lamour, Daphne T. Hsu, Maryanne R. Kichuk, Mark E. Galantowicz, Jan M. Quaegebeur, Linda J. Addonizio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Pulmonary arteriovenous malformations (PAVMs) can occur following caval to pulmonary artery connection, Glenn and/or Fontan procedure, leading to severe cyanosis and exercise intolerance. It is unknown whether these abnormalities regress or persist following heart transplantation (HTx). Twenty patients with failed Fontan or Glenn procedures were screened for PAVMs prior to HTx by contrast echocardiography, selective pulmonary angiography, and pulmonary venous desaturation. Age at transplant, diagnosis, previous operations, time from Glenn to transplant, systemic oxygenation, hemoglobin level, and ventricular function were determined. The clinical course after HTx was characterized in three patients with significant PAVMs. Indications for HTx were exercise intolerance and severe cyanosis in one patient, and cyanosis and ventricular dysfunction in two. Pre-HTx, mean systemic saturation was 67%; mean pulmonary venous wedge saturation was 81%. Post-HTx, oxygen saturations were normal (>96%) at 14, 40, and 180 days. Contrast echocardiography, performed 1 month to 3.3 yrs after HTx, showed no intrapulmonary shunting in two patients and minimal shunting in one. One patient suffered an embolic stroke from right-to-left shunting post-HTx. All patients are alive and well 35, 71, and 73 months post-HTx. In patients with single ventricle physiology, PAVMs are not an absolute contraindication to HTx. Heart-lung transplant may not be required for these patients.

Original languageEnglish (US)
Pages (from-to)280-284
Number of pages5
JournalPediatric Transplantation
Volume4
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Congenital Heart Defects
Arteriovenous Malformations
Heart Transplantation
Lung
Cyanosis
Transplants
Echocardiography
Exercise
Fontan Procedure
Ventricular Dysfunction
Venae Cavae
Ventricular Function
Pulmonary Artery
Angiography
Hemoglobins
Stroke
Oxygen

Keywords

  • Congenital
  • Heart defects
  • Pulmonary arteriovenous malformations
  • Transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Regression of pulmonary arteriovenous malformations following heart transplantation. / Lamour, Jacqueline M.; Hsu, Daphne T.; Kichuk, Maryanne R.; Galantowicz, Mark E.; Quaegebeur, Jan M.; Addonizio, Linda J.

In: Pediatric Transplantation, Vol. 4, No. 4, 2000, p. 280-284.

Research output: Contribution to journalArticle

Lamour, Jacqueline M. ; Hsu, Daphne T. ; Kichuk, Maryanne R. ; Galantowicz, Mark E. ; Quaegebeur, Jan M. ; Addonizio, Linda J. / Regression of pulmonary arteriovenous malformations following heart transplantation. In: Pediatric Transplantation. 2000 ; Vol. 4, No. 4. pp. 280-284.
@article{76bd90b3709340d9b11e08ea36664bc2,
title = "Regression of pulmonary arteriovenous malformations following heart transplantation",
abstract = "Pulmonary arteriovenous malformations (PAVMs) can occur following caval to pulmonary artery connection, Glenn and/or Fontan procedure, leading to severe cyanosis and exercise intolerance. It is unknown whether these abnormalities regress or persist following heart transplantation (HTx). Twenty patients with failed Fontan or Glenn procedures were screened for PAVMs prior to HTx by contrast echocardiography, selective pulmonary angiography, and pulmonary venous desaturation. Age at transplant, diagnosis, previous operations, time from Glenn to transplant, systemic oxygenation, hemoglobin level, and ventricular function were determined. The clinical course after HTx was characterized in three patients with significant PAVMs. Indications for HTx were exercise intolerance and severe cyanosis in one patient, and cyanosis and ventricular dysfunction in two. Pre-HTx, mean systemic saturation was 67{\%}; mean pulmonary venous wedge saturation was 81{\%}. Post-HTx, oxygen saturations were normal (>96{\%}) at 14, 40, and 180 days. Contrast echocardiography, performed 1 month to 3.3 yrs after HTx, showed no intrapulmonary shunting in two patients and minimal shunting in one. One patient suffered an embolic stroke from right-to-left shunting post-HTx. All patients are alive and well 35, 71, and 73 months post-HTx. In patients with single ventricle physiology, PAVMs are not an absolute contraindication to HTx. Heart-lung transplant may not be required for these patients.",
keywords = "Congenital, Heart defects, Pulmonary arteriovenous malformations, Transplantation",
author = "Lamour, {Jacqueline M.} and Hsu, {Daphne T.} and Kichuk, {Maryanne R.} and Galantowicz, {Mark E.} and Quaegebeur, {Jan M.} and Addonizio, {Linda J.}",
year = "2000",
doi = "10.1034/j.1399-3046.2000.00126.x",
language = "English (US)",
volume = "4",
pages = "280--284",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Regression of pulmonary arteriovenous malformations following heart transplantation

AU - Lamour, Jacqueline M.

AU - Hsu, Daphne T.

AU - Kichuk, Maryanne R.

AU - Galantowicz, Mark E.

AU - Quaegebeur, Jan M.

AU - Addonizio, Linda J.

PY - 2000

Y1 - 2000

N2 - Pulmonary arteriovenous malformations (PAVMs) can occur following caval to pulmonary artery connection, Glenn and/or Fontan procedure, leading to severe cyanosis and exercise intolerance. It is unknown whether these abnormalities regress or persist following heart transplantation (HTx). Twenty patients with failed Fontan or Glenn procedures were screened for PAVMs prior to HTx by contrast echocardiography, selective pulmonary angiography, and pulmonary venous desaturation. Age at transplant, diagnosis, previous operations, time from Glenn to transplant, systemic oxygenation, hemoglobin level, and ventricular function were determined. The clinical course after HTx was characterized in three patients with significant PAVMs. Indications for HTx were exercise intolerance and severe cyanosis in one patient, and cyanosis and ventricular dysfunction in two. Pre-HTx, mean systemic saturation was 67%; mean pulmonary venous wedge saturation was 81%. Post-HTx, oxygen saturations were normal (>96%) at 14, 40, and 180 days. Contrast echocardiography, performed 1 month to 3.3 yrs after HTx, showed no intrapulmonary shunting in two patients and minimal shunting in one. One patient suffered an embolic stroke from right-to-left shunting post-HTx. All patients are alive and well 35, 71, and 73 months post-HTx. In patients with single ventricle physiology, PAVMs are not an absolute contraindication to HTx. Heart-lung transplant may not be required for these patients.

AB - Pulmonary arteriovenous malformations (PAVMs) can occur following caval to pulmonary artery connection, Glenn and/or Fontan procedure, leading to severe cyanosis and exercise intolerance. It is unknown whether these abnormalities regress or persist following heart transplantation (HTx). Twenty patients with failed Fontan or Glenn procedures were screened for PAVMs prior to HTx by contrast echocardiography, selective pulmonary angiography, and pulmonary venous desaturation. Age at transplant, diagnosis, previous operations, time from Glenn to transplant, systemic oxygenation, hemoglobin level, and ventricular function were determined. The clinical course after HTx was characterized in three patients with significant PAVMs. Indications for HTx were exercise intolerance and severe cyanosis in one patient, and cyanosis and ventricular dysfunction in two. Pre-HTx, mean systemic saturation was 67%; mean pulmonary venous wedge saturation was 81%. Post-HTx, oxygen saturations were normal (>96%) at 14, 40, and 180 days. Contrast echocardiography, performed 1 month to 3.3 yrs after HTx, showed no intrapulmonary shunting in two patients and minimal shunting in one. One patient suffered an embolic stroke from right-to-left shunting post-HTx. All patients are alive and well 35, 71, and 73 months post-HTx. In patients with single ventricle physiology, PAVMs are not an absolute contraindication to HTx. Heart-lung transplant may not be required for these patients.

KW - Congenital

KW - Heart defects

KW - Pulmonary arteriovenous malformations

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0033783872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033783872&partnerID=8YFLogxK

U2 - 10.1034/j.1399-3046.2000.00126.x

DO - 10.1034/j.1399-3046.2000.00126.x

M3 - Article

C2 - 11079267

AN - SCOPUS:0033783872

VL - 4

SP - 280

EP - 284

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 4

ER -